GlassScriptPhysician profile
Abdullah Hanif Malik
NPI 1245680164
$18,227.64
in general payments reported to CMS, 2019-2025
25 companies · $2,068 in 2025
The $2,068 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.53 · 2021: $347 · 2022: $660 · 2023: $770 · 2024: $14K · 2025: $2,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $4,048 · Education: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,524.45 |
| Food and Beverage | $4,047.51 |
| Education | $637.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $13,085.47 | 2021-2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, (7881) US Und |
| Abbott Laboratories | $1,594.34 | 2021-2025 | Optis, Ensite, Coroflow |
| Medtronic, INC. | $794.93 | 2022-2025 | Onyx Frontier, Micra, Hawkone |
| Abiomed | $487.27 | 2024-2025 | Impella |
| Shockwave Medical, INC | $255.38 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $248.60 | 2023-2025 | Lifevest |
| Becton, Dickinson and Company | $178.11 | 2025 | Rotarexs 6 F X 135 Cm |
| Kestra Medical Technology Services, INC. | $167.41 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $159.76 | 2025 | |
| Cardiva Medical, INC. | $158.03 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $149.45 | 2023 | Opticross |
| Inari Medical, INC. | $144.01 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $140.18 | 2023-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $129.12 | 2025 | Gore Cardioform Septal Occluder |
| Chiesi USA, INC. | $121.79 | 2023-2025 | Kengreal, Cleviprex |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $99.99 | 2021 | |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Imperative Care, INC | $79.88 | 2025 | Symphony Catheter |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Pfizer INC. | $18.98 | 2024 | |
| Merck Sharp & Dohme LLC | $18.96 | 2024 | Verquvo |
| Bard Peripheral Vascular, INC. | $17.51 | 2025 | Rotarexs 6 F X 135 Cm |
| Amgen INC. | $15.60 | 2025 | Repatha |
| Novo Nordisk INC | $14.59 | 2024 | Rybelsus, Ozempic |
| Abbvie INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.